GlassScriptPhysician profile
Oliver W Horne
NPI 1053610642
$12,183.60
in general payments reported to CMS, 2019-2025
28 companies · $4,923 in 2025
The $4,923 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,928 · 2020: $411 · 2021: $918 · 2022: $850 · 2023: $829 · 2024: $324 · 2025: $4,923.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,775 · Food and Beverage: $2,159 · Travel and Lodging: $1,143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,775.00 |
| Food and Beverage | $2,158.50 |
| Travel and Lodging | $1,143.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,405.24 | 2021-2025 | Affera Mapping System, Na, Paceart System Ecg Module |
| Medtronic Vascular, INC. | $2,889.17 | 2019-2020 | |
| Abbott Laboratories | $932.61 | 2019-2023 | Advisor, Perclose Prostyle |
| Novartis Pharmaceuticals Corporation | $559.68 | 2019-2025 | |
| Boston Scientific Corporation | $433.42 | 2019-2025 | Watchman Flx, Jetstream Sc, Lux-Dx Insertable Cardiac Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $340.65 | 2019-2025 | Lifevest |
| Biotronik INC. | $278.41 | 2019 | |
| Pfizer INC. | $274.03 | 2019-2025 | |
| Elutia, INC. | $141.11 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $139.92 | 2021-2024 | Farxiga |
| Janssen Pharmaceuticals, INC | $130.62 | 2023-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $101.96 | 2020-2025 | Eliquis, Camzyos |
| Merck Sharp & Dohme LLC | $100.89 | 2023-2025 | Verquvo |
| Philips North America LLC | $89.36 | 2021 | |
| Amarin Pharma, INC. | $52.28 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $47.15 | 2021-2025 | Repatha, Repatha |
| Biosense Webster, INC. | $36.89 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $35.99 | 2021 | |
| Alnylam Pharmaceuticals INC. | $34.42 | 2023-2024 | Onpattro, Amvuttra |
| Sanofi-Aventis U.S. LLC | $33.08 | 2019-2024 | |
| Edwards Lifesciences Corporation | $27.59 | 2025 | Sapien 3 Ultra Resilia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.26 | 2019 | |
| Esperion Therapeutics, INC. | $16.89 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.17 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $15.18 | 2024 | Arcalyst |
| Acutus Medical, INC. | $11.59 | 2021 | |
| Cardiva Medical, INC. | $11.05 | 2021 | |
| Vivaquant INC, Dba Rhythm Express | $5.99 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oliver Horne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.